A high-throughput assay for the detection of Tyr-phosphorylated proteins in urine of bladder cancer patients (original) (raw)

Guidelines for development of diagnostic markers in bladder cancer

Peter Goebell

World Journal of Urology, 2008

View PDFchevron_right

Evidence of Abnormal Tyrosine Phosphorylated Proteins in the Urine of Patients With Bladder Cancer: The Road Toward a New Diagnostic Tool?

P. Destefanis

The Journal of Urology, 2011

View PDFchevron_right

The clinical relevance of urine-based markers for diagnosis of bladder cancer

amr amin

Medical Oncology, 2011

View PDFchevron_right

Polyclonal antibody from 47 kDa protein of bladder cancer is sensitive and specific for detection of bladder cancer

Basuki Purnomo

Biomarkers and Genomic Medicine, 2014

View PDFchevron_right

A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer

andi abeshi

Bladder Cancer, 2016

View PDFchevron_right

Novel aspects of clinical and pathological prognostic markers of urinary bladder and kidney cancers

János Révész

View PDFchevron_right

Erratum to "Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer" [Gene 626C (2017) 407-413]

Azwar Anas

Gene, 2017

View PDFchevron_right

A Rapid Screening Assay to Search for Phosphorylated Proteins in Tissue Extracts

Ignazio Garaguso

PLoS ONE, 2012

View PDFchevron_right

Identification of Genes Correlated with Early-Stage Bladder Cancer Progression

Raja loganantharaj

Cancer Prevention Research, 2010

View PDFchevron_right

Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer

Mahmoud Elrouby

Asian Pacific Journal of Cancer Prevention, 2015

View PDFchevron_right

Urinary Bladder Cancer Susceptibility Markers. What Do We Know about Functional Mechanisms?

Gerald Verhaegh

International Journal of Molecular Sciences, 2013

View PDFchevron_right

Urinary Markers in Bladder Cancer: An Update

Maria Morelli

Frontiers in Oncology, 2018

View PDFchevron_right

Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder Lesions

Kiril Trpkov

The American Journal of Surgical Pathology, 2014

View PDFchevron_right

HTRF® Total and Phospho-YAP (Ser127) Cellular Assays

merve bilgiç

Methods in Molecular Biology, 2018

View PDFchevron_right

In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice

Christos Alamanis

Archivio italiano di urologia, andrologia, 2016

View PDFchevron_right

Urinary Biomarkers for the Early Diagnosis of Kidney Cancer

Jeremiah Morrissey

Mayo Clinic Proceedings, 2010

View PDFchevron_right

Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer

Natasha Chokrevska Zografska

Proteome Science, 2015

View PDFchevron_right

Urine and Serum Cathepsin B Concentrations in the Transitional Cell Carcinoma of the Bladder

Prusa Richard

Journal of Clinical Laboratory Analysis, 2012

View PDFchevron_right

A rapid direct assay for uroporphyrinogen III cosynthetase

Gerardo Burton

FEBS Letters, 1980

View PDFchevron_right

Molecular Detection of Genetic Susceptibility to Bladder Cancer in Egyptian Patients

Tarek Aboushousha

Asian Pacific Journal of Cancer Prevention, 2022

View PDFchevron_right

Urine Telomerase: An Important Marker in the Diagnosis of Bladder Cancer

Sara Bravaccini

Neoplasia, 2004

View PDFchevron_right

SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer

Dan Burghelea

2022

View PDFchevron_right

Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel–Lindau patients

Giorgia Mandili

Biomarkers, 2016

View PDFchevron_right

PAX8 expression in human bladder cancer

Francesca Saro

Oncology Reports, 2006

View PDFchevron_right

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer

Marta Sanchez-carbayo

Urologic Oncology: Seminars and Original Investigations, 2010

View PDFchevron_right

Use of Proteins as Biomarkers and Their Role in Carcinogenesis

G. Pitsiou

Journal of Cancer, 2015

View PDFchevron_right

Differential activities of protein tyrosine phosphatases in intact cells

J. Schlessinger

Journal of Biological Chemistry, 1993

View PDFchevron_right

Urine protein biomarkers for the detection, surveillance, and treatment response prediction of bladder cancer

Ashish Chakraborty

American journal of cancer research, 2019

View PDFchevron_right

Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors

Maria Quarto

Oncology, 2009

View PDFchevron_right

Single cell network profiling assay in bladder cancer

Alessandra Cesano

Cytometry Part A, 2013

View PDFchevron_right

New Screening Diagnostic Techniques in Urinalysis

Joris Delanghe

Acta Clinica Belgica, 2007

View PDFchevron_right

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation

Anders Christiansen

PLoS ONE, 2012

View PDFchevron_right

Bladder cancer

Öner M Şanlı

Nature Reviews Disease Primers, 2017

View PDFchevron_right

Clinical and biochemical study of three patients with tyrosyluria

Sang Kooh

PubMed, 1967

View PDFchevron_right

Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?

Benjamin Nisman

Expert Review of Anticancer Therapy, 2010

View PDFchevron_right